Clinical characteristics of insulin resistant and non-insulin resistant obese and control children/adolescents.

Data represent mean±SD;*, p†, pIR+, insulin resistant obese subjects; IR-, non-insulin resistant obese subjects; HOMA-IR, homeostasis model assessment of insulin resistance; hsCRP, high sensitivity C-reactive protein; LFRR, low frequency power of R-R variability; nu, normalized units; HFRR, high frequency power of R-R variability; LFSBP, low frequency power of systolic blood pressure variability.Clinical characteristics of insulin resistant and non-insulin resistant obese and control children/adolescents.数据以均值±标准差（mean±SD）表示；*、p†、pIR+ 指代胰岛素抵抗肥胖受试者，IR-指代非胰岛素抵抗肥胖受试者；HOMA-IR（homeostasis model assessment of insulin resistance）即胰岛素抵抗稳态模型评估；hsCRP（high sensitivity C-reactive protein）即高敏C反应蛋白；LFRR（low frequency power of R-R variability）即R-R间期变异性低频功率；nu（normalized units）即归一化单位；HFRR（high frequency power of R-R variability）即R-R间期变异性高频功率；LFSBP（low frequency power of systolic blood pressure variability）即收缩压变异性低频功率。本数据集涵盖胰岛素抵抗肥胖、非胰岛素抵抗肥胖儿童及青少年与对照组的临床特征。